,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.1,Atrophy,17043879,
0,22.1,Hospice care,17043883,
0,22.1,Death,17043903,5
0,22.1,Lower respiratory tract infection,17043974,6
1,22.1,Depressed mood,17043974,6
0,22.1,Atrial fibrillation,17043975,6
1,22.1,Pyrexia,17043975,1
0,22.1,Papillary thyroid cancer,17044012,6
1,22.1,Malignant neoplasm progression,17044012,6
2,22.1,Product use in unapproved indication,17044012,6
0,22.1,Death,17044088,5
0,22.1,Leukopenia,17044101,1
1,22.1,Agranulocytosis,17044101,1
0,22.1,Neuropathy peripheral,17044105,3
1,22.1,Productive cough,17044105,6
2,22.1,Eczema,17044105,2
3,22.1,Nocturia,17044105,6
4,22.1,Oral pain,17044105,2
5,22.1,Lip oedema,17044105,2
6,22.1,Lip pain,17044105,2
0,22.1,Intervertebral disc operation,17044139,2
1,22.1,Spinal laminectomy,17044139,2
2,22.1,Postoperative wound complication,17044139,2
3,22.1,Malaise,17044139,6
4,22.1,Arthralgia,17044139,2
5,22.1,Surgery,17044139,6
6,22.1,Back pain,17044139,2
7,22.1,Skin discolouration,17044139,6
8,22.1,Pain in extremity,17044139,2
9,22.1,Post procedural complication,17044139,6
0,22.1,Dehydration,17044146,
1,22.1,Loss of consciousness,17044146,
0,22.1,Lung carcinoma cell type unspecified stage IV,17044151,5
0,22.1,Skin toxicity,17044155,3
1,22.1,Off label use,17044155,6
0,22.1,Paraplegia,17044191,6
0,22.1,Malignant neoplasm progression,17044203,6
1,22.1,Skin reaction,17044203,6
2,22.1,Myalgia,17044203,6
3,22.1,Pneumonitis,17044203,6
4,22.1,Toxicity to various agents,17044203,6
5,22.1,Off label use,17044203,6
6,22.1,Herpes zoster,17044203,6
7,22.1,Troponin increased,17044203,6
8,22.1,Muscle discomfort,17044203,6
9,22.1,Atrial fibrillation,17044203,6
0,22.1,Asthenia,17044227,3
1,22.1,Neutropenia,17044227,6
2,22.1,Spinal pain,17044227,2
3,22.1,Alopecia,17044227,6
4,22.1,Dyspnoea,17044227,2
5,22.1,Musculoskeletal chest pain,17044227,6
6,22.1,Musculoskeletal discomfort,17044227,6
7,22.1,Back pain,17044227,6
0,22.1,Abdominal distension,17044272,3
1,22.1,Cough,17044272,3
2,22.1,Dyspnoea,17044272,3
3,22.1,Abdominal pain,17044272,3
4,22.1,Pruritus,17044272,3
5,22.1,Pyrexia,17044272,3
0,22.1,Product adhesion issue,17044273,
1,22.1,Product substitution issue,17044273,
2,22.1,Drug withdrawal syndrome,17044273,
0,22.1,Malignant neoplasm progression,17044279,6
1,22.1,Malignant neoplasm progression,17044279,6
2,22.1,Metastases to lymph nodes,17044279,6
3,22.1,Metastatic neoplasm,17044279,6
4,22.1,Diabetic ketoacidotic hyperglycaemic coma,17044279,6
5,22.1,Diabetes mellitus,17044279,6
6,22.1,Malignant neoplasm progression,17044279,6
7,22.1,Lymphadenopathy,17044279,6
8,22.1,Metastases to the mediastinum,17044279,6
9,22.1,Metastases to the mediastinum,17044279,6
10,22.1,Acute kidney injury,17044279,6
11,22.1,Metastases to lymph nodes,17044279,6
12,22.1,Metastases to the mediastinum,17044279,6
13,22.1,Malignant neoplasm progression,17044279,6
14,22.1,Lung neoplasm malignant,17044279,6
15,22.1,Metastases to lymph nodes,17044279,6
16,22.1,Lung cancer metastatic,17044279,6
17,22.1,Thrombocytopenia,17044279,6
0,22.1,Death,17044301,5
0,22.1,Inappropriate schedule of product administration,17044308,6
1,22.1,Malignant neoplasm progression,17044308,5
0,22.1,White blood cell count decreased,17044347,2
1,22.1,Urinary tract infection,17044347,6
2,22.1,Arthralgia,17044347,2
3,22.1,Fatigue,17044347,2
4,22.1,Hot flush,17044347,6
5,22.1,Madarosis,17044347,6
0,22.1,Death,17044367,5
0,22.1,Death,17044412,5
0,22.1,Prostate cancer,17044438,5
0,22.1,Dysphagia,17044467,3
1,22.1,Oropharyngeal pain,17044467,1
2,22.1,Pain,17044467,3
3,22.1,Mobility decreased,17044467,6
4,22.1,Decreased appetite,17044467,6
5,22.1,Nausea,17044467,3
6,22.1,Depression,17044467,6
7,22.1,Non-small cell lung cancer metastatic,17044467,1
8,22.1,Gastrointestinal disorder,17044467,6
9,22.1,Sleep disorder,17044467,6
10,22.1,Gait disturbance,17044467,6
11,22.1,Glossodynia,17044467,6
12,22.1,Paraesthesia,17044467,3
13,22.1,Fatigue,17044467,3
14,22.1,Dyspnoea,17044467,3
15,22.1,Pain in extremity,17044467,6
16,22.1,Chest pain,17044467,1
17,22.1,Alopecia,17044467,6
18,22.1,Dry mouth,17044467,3
19,22.1,Memory impairment,17044467,3
20,22.1,Depressed mood,17044467,6
21,22.1,Somnolence,17044467,3
22,22.1,Cough,17044467,6
23,22.1,Musculoskeletal pain,17044467,6
24,22.1,Oral pain,17044467,6
25,22.1,Emotional distress,17044467,3
26,22.1,Constipation,17044467,1
0,22.1,Flushing,17044489,1
1,22.1,Erythema,17044489,1
2,22.1,Dyspnoea,17044489,1
3,22.1,Hypotension,17044489,1
0,22.1,Malignant pleural effusion,17044510,6
1,22.1,Malignant neoplasm progression,17044510,6
2,22.1,Drug resistance,17044510,6
0,22.1,Acute hepatitis B,17044512,5
0,22.1,Colitis,17044559,1
1,22.1,Diarrhoea,17044559,1
2,22.1,Dizziness,17044559,3
0,22.1,Fatigue,17044563,6
1,22.1,Intentional product use issue,17044563,6
0,22.1,Anaemia,17044580,6
1,22.1,Nausea,17044580,3
2,22.1,Headache,17044580,6
3,22.1,Decreased appetite,17044580,3
4,22.1,Fatigue,17044580,3
5,22.1,Asthenia,17044580,6
0,22.1,Neoplasm progression,17044606,6
1,22.1,Death,17044606,5
0,22.1,Sinusitis,17044608,6
1,22.1,Nasopharyngitis,17044608,6
2,22.1,Asthenia,17044608,6
3,22.1,Confusional state,17044608,6
0,22.1,Skin ulcer,17044634,6
1,22.1,Cytomegalovirus test positive,17044634,1
2,22.1,Cellulitis,17044634,2
3,22.1,Paronychia,17044634,6
4,22.1,Malaise,17044634,6
0,22.1,Diarrhoea,17044661,6
1,22.1,Fatigue,17044661,3
2,22.1,Dyspepsia,17044661,6
3,22.1,Blood glucose increased,17044661,6
0,22.1,Feeding disorder,17044671,6
1,22.1,Weight decreased,17044671,6
2,22.1,Decreased appetite,17044671,6
3,22.1,Malaise,17044671,6
4,22.1,Fatigue,17044671,6
5,22.1,Death,17044671,5
6,22.1,Haematuria,17044671,6
7,22.1,Nausea,17044671,6
0,22.1,Death,17044711,5
0,22.1,Pyelonephritis acute,17044759,6
1,22.1,Cholangitis infective,17044759,6
2,22.1,Disseminated intravascular coagulation,17044759,6
3,22.1,Pollakiuria,17044759,1
4,22.1,Sepsis,17044759,6
5,22.1,Bile duct stone,17044759,6
6,22.1,Hypokalaemia,17044759,6
7,22.1,Hyperbilirubinaemia,17044759,6
8,22.1,Ureterolithiasis,17044759,6
9,22.1,Hypertension,17044759,6
10,22.1,Nephrolithiasis,17044759,6
11,22.1,Micturition urgency,17044759,1
0,22.1,Nausea,17044772,1
1,22.1,Vomiting,17044772,1
2,22.1,Inappropriate schedule of product administration,17044772,1
3,22.1,Abdominal pain,17044772,1
0,22.1,Decreased appetite,17044854,3
1,22.1,Fatigue,17044854,3
2,22.1,Cerebrovascular accident,17044854,6
3,22.1,Abdominal pain,17044854,3
4,22.1,Nausea,17044854,3
5,22.1,Diarrhoea,17044854,2
6,22.1,Weight decreased,17044854,3
0,22.1,Bladder neoplasm surgery,17044861,2
1,22.1,Product availability issue,17044861,6
0,22.1,Ascites,17044885,3
1,22.1,Tumour marker increased,17044885,3
0,22.1,Delirium,17044924,3
0,22.1,Alopecia,17045025,2
0,22.1,Alopecia,17045048,2
1,22.1,Psychological trauma,17045048,6
0,22.1,Pain,17045077,6
1,22.1,Impaired quality of life,17045077,6
2,22.1,Anxiety,17045077,6
3,22.1,Emotional distress,17045077,6
4,22.1,Alopecia,17045077,2
0,22.1,Peripheral swelling,17045140,6
1,22.1,Tremor,17045140,6
2,22.1,Headache,17045140,6
3,22.1,Pain in extremity,17045140,6
4,22.1,Swelling face,17045140,6
0,22.1,Diarrhoea,17045151,6
0,22.1,Nephropathy toxic,17045178,6
0,22.1,Progressive multifocal leukoencephalopathy,17045224,6
0,22.1,Febrile neutropenia,17045248,4
1,22.1,Colitis ischaemic,17045248,4
0,22.1,Spinal pain,17045252,3
1,22.1,Chills,17045252,1
2,22.1,Dental fistula,17045252,6
3,22.1,Vision blurred,17045252,1
4,22.1,Night sweats,17045252,6
0,22.1,Cellulitis of male external genital organ,17045442,6
0,22.1,Dysphonia,17045620,3
0,22.1,General physical health deterioration,17045646,6
1,22.1,Breast cancer,17045646,6
2,22.1,Malignant neoplasm progression,17045646,6
0,22.1,Fatigue,17045694,3
1,22.1,Nausea,17045694,4
2,22.1,Bone pain,17045694,4
0,22.1,Anaphylactic reaction,17045708,1
0,22.1,Haematuria,17045710,2
1,22.1,Abdominal pain,17045710,2
0,22.1,Cystitis haemorrhagic,17045711,6
1,22.1,Haematuria,17045711,2
2,22.1,Haematuria,17045711,1
0,22.1,Gait disturbance,17045781,6
1,22.1,Haematoma,17045781,6
0,22.1,Agranulocytosis,17045846,1
0,22.1,Acute kidney injury,17045857,6
1,22.1,Diabetes mellitus,17045857,6
0,22.1,Disease progression,17045866,6
0,22.1,Metastases to central nervous system,17045875,4
0,22.1,Pyrexia,17045892,1
1,22.1,Rash,17045892,1
0,22.1,Neuropathy peripheral,17045968,6
1,22.1,Hypoaesthesia,17045968,6
2,22.1,Paraesthesia,17045968,6
0,22.1,Gastrointestinal toxicity,17045975,6
1,22.1,Toxicity to various agents,17045975,6
0,22.1,Lung disorder,17045979,2
0,22.1,Visual impairment,17046005,2
1,22.1,Dyskinesia,17046005,2
2,22.1,Memory impairment,17046005,2
3,22.1,Drug interaction,17046005,2
4,22.1,Ataxia,17046005,2
5,22.1,Confusional state,17046005,2
6,22.1,Photophobia,17046005,2
7,22.1,Headache,17046005,2
8,22.1,Toxicity to various agents,17046005,2
0,22.1,Angina unstable,17046023,4
0,22.1,Malignant pleural effusion,17046059,5
0,22.1,Vertigo,17046088,1
0,22.1,Rash,17046091,2
1,22.1,Dermatomyositis,17046091,2
0,22.1,Gastrointestinal toxicity,17046120,6
1,22.1,Haematotoxicity,17046120,6
0,22.1,Ileus,17046124,1
1,22.1,Pancreatic carcinoma,17046124,3
0,22.1,Cardiac ventricular thrombosis,17046126,6
0,22.1,Death,17046129,5
0,22.1,Adrenocorticotropic hormone deficiency,17046130,4
1,22.1,Secondary adrenocortical insufficiency,17046130,4
0,22.1,Asthenia,17046132,6
1,22.1,Nausea,17046132,6
2,22.1,Anxiety,17046132,6
3,22.1,Neutropenia,17046132,6
0,22.1,Benign prostatic hyperplasia,17046133,6
1,22.1,Abdominal wall haematoma,17046133,1
2,22.1,Abdominal injury,17046133,6
3,22.1,Diabetes mellitus,17046133,6
4,22.1,Hypertonic bladder,17046133,6
0,22.1,Infusion related reaction,17046141,1
0,22.1,Blindness,17046148,6
1,22.1,Nausea,17046148,6
2,22.1,Vomiting,17046148,6
3,22.1,Vision blurred,17046148,6
4,22.1,Nystagmus,17046148,6
5,22.1,Inappropriate schedule of product administration,17046148,6
0,22.1,Hypotension,17046164,6
0,22.1,Dry eye,17046265,1
1,22.1,Eye pain,17046265,6
2,22.1,Ocular discomfort,17046265,6
3,22.1,Arthralgia,17046265,1
0,22.1,Myelitis,17046293,1
0,22.1,Urticaria,17046317,6
1,22.1,Burning sensation,17046317,6
2,22.1,Rash,17046317,6
0,22.1,Type 2 diabetes mellitus,17046333,3
1,22.1,Atrial fibrillation,17046333,6
2,22.1,Diabetic ketoacidosis,17046333,6
3,22.1,Glycosylated haemoglobin increased,17046333,6
4,22.1,Neutropenic sepsis,17046333,6
0,22.1,Cataract,17046391,6
0,22.1,Nasopharyngitis,17046412,6
1,22.1,Asthenia,17046412,6
2,22.1,Death,17046412,5
3,22.1,Pyrexia,17046412,6
0,22.1,Pulmonary sepsis,17046421,6
1,22.1,Pyrexia,17046421,6
2,22.1,Malignant neoplasm progression,17046421,6
0,22.1,Pneumothorax,17046431,6
0,22.1,Pneumonitis,17046445,6
0,22.1,Malignant neoplasm progression,17046497,6
1,22.1,Lung disorder,17046497,6
2,22.1,Non-small cell lung cancer metastatic,17046497,6
0,22.1,Death,17046540,5
0,22.1,Haemorrhage,17046555,6
1,22.1,Nausea,17046555,6
2,22.1,Vomiting,17046555,6
3,22.1,Drug interaction,17046555,6
4,22.1,Depressed level of consciousness,17046555,6
0,22.1,Pyrexia,17046562,6
1,22.1,Chills,17046562,6
2,22.1,Neutropenic sepsis,17046562,3
0,22.1,Erythema,17046585,6
0,22.1,Febrile neutropenia,17046594,6
1,22.1,Rectal cancer,17046594,5
2,22.1,Gastric cancer,17046594,5
0,22.1,Rash,17046654,3
0,22.1,Drug abuse,17046695,6
1,22.1,Methaemoglobinaemia,17046695,6
0,22.1,Dacryostenosis acquired,17046708,6
1,22.1,Gastrointestinal disorder,17046708,6
2,22.1,Pruritus,17046708,6
3,22.1,Off label use,17046708,6
4,22.1,Polyneuropathy,17046708,6
5,22.1,Hot flush,17046708,6
0,22.1,Drug ineffective,17046752,6
1,22.1,Fatigue,17046752,6
2,22.1,Hepatic neoplasm,17046752,6
3,22.1,Diarrhoea,17046752,6
4,22.1,Malignant neoplasm progression,17046752,6
0,22.1,Toxic epidermal necrolysis,17046767,5
1,22.1,Pulmonary embolism,17046767,5
2,22.1,Pneumonia,17046767,5
3,22.1,Radiation pneumonitis,17046767,5
0,22.1,Cardiac disorder,17046829,1
1,22.1,Intentional dose omission,17046829,3
0,22.1,Metastases to bone,17046878,6
1,22.1,Back pain,17046878,6
2,22.1,Abdominal pain lower,17046878,6
3,22.1,Metastases to lymph nodes,17046878,6
4,22.1,Cerebral haemorrhage,17046878,5
5,22.1,Injection site bruising,17046878,6
6,22.1,Disseminated intravascular coagulation,17046878,5
7,22.1,Malignant neoplasm progression,17046878,6
8,22.1,Lymphadenopathy,17046878,6
9,22.1,Platelet count decreased,17046878,5
10,22.1,Infection,17046878,5
11,22.1,Haemoptysis,17046878,6
0,22.1,Hospice care,17046931,6
0,22.1,Nausea,17046946,3
1,22.1,Hepatic enzyme increased,17046946,3
0,22.1,Malignant neoplasm progression,17046953,5
1,22.1,Dermatitis acneiform,17046953,6
0,22.1,Malignant neoplasm progression,17047023,6
1,22.1,Drug resistance,17047023,6
0,22.1,Hepatotoxicity,17047061,6
0,22.1,Hyperammonaemia,17047120,6
1,22.1,Altered state of consciousness,17047120,6
0,22.1,Mental disorder,17047140,1
1,22.1,Abdominal distension,17047140,1
2,22.1,Hypoaesthesia,17047140,2
3,22.1,Muscle spasms,17047140,2
4,22.1,Dizziness,17047140,2
5,22.1,Headache,17047140,2
6,22.1,Urinary retention,17047140,3
0,22.1,Disease progression,17047141,6
0,22.1,Hepatic function abnormal,17047145,6
0,22.1,Dyspepsia,17047149,6
1,22.1,Malaise,17047149,6
2,22.1,Limb discomfort,17047149,6
3,22.1,Asthenia,17047149,6
4,22.1,Flatulence,17047149,6
5,22.1,Arthralgia,17047149,6
6,22.1,Diarrhoea,17047149,6
0,22.1,Urinary retention,17047150,6
0,22.1,Dermatitis,17047177,6
0,22.1,Diabetes mellitus,17047223,6
0,22.1,Bronchospasm,17047301,1
1,22.1,Flushing,17047301,2
0,22.1,Bone marrow failure,17047306,2
0,22.1,Posterior reversible encephalopathy syndrome,17047333,6
1,22.1,Swollen tongue,17047333,6
2,22.1,Swelling,17047333,6
3,22.1,Throat tightness,17047333,6
4,22.1,Dysgeusia,17047333,6
0,22.1,Death,17047341,5
0,22.1,Hyperkalaemia,17047434,6
0,22.1,Shock haemorrhagic,17047457,5
1,22.1,Haemorrhage,17047457,5
0,22.1,Syncope,17047488,6
1,22.1,Feeling abnormal,17047488,6
2,22.1,Visual impairment,17047488,6
0,22.1,Drug ineffective,17047521,3
0,22.1,Death,17047674,5
0,22.1,Blood pressure increased,17047727,2
1,22.1,Back pain,17047727,2
2,22.1,Dyspepsia,17047727,2
3,22.1,Drug interaction,17047727,6
4,22.1,Chest pain,17047727,2
0,22.1,Knee operation,17047777,6
0,22.1,Blood pressure increased,17047784,1
1,22.1,Dyspnoea,17047784,1
2,22.1,Nausea,17047784,1
3,22.1,Chills,17047784,1
4,22.1,Flushing,17047784,1
5,22.1,Paraesthesia,17047784,1
0,22.1,Dyspnoea,17047789,
1,22.1,Infusion related reaction,17047789,
2,22.1,Chest discomfort,17047789,
0,22.1,Hypersensitivity,17047794,1
1,22.1,Hypertension,17047794,1
2,22.1,Pruritus,17047794,1
3,22.1,Tachycardia,17047794,1
4,22.1,Throat irritation,17047794,1
0,22.1,Flushing,17047813,6
1,22.1,Feeling hot,17047813,6
2,22.1,Headache,17047813,6
0,22.1,Hot flush,17047814,1
1,22.1,Product use in unapproved indication,17047814,6
2,22.1,Off label use,17047814,6
3,22.1,Dizziness,17047814,1
4,22.1,Dyspnoea,17047814,1
5,22.1,Palpitations,17047814,1
0,22.1,Chest discomfort,17047815,1
1,22.1,Dyspnoea,17047815,1
0,22.1,Drug hypersensitivity,17047818,1
1,22.1,Hypotension,17047818,1
2,22.1,Erythema,17047818,1
3,22.1,Dyspnoea,17047818,1
4,22.1,Eye swelling,17047818,1
0,22.1,Product use in unapproved indication,17047822,6
1,22.1,Back pain,17047822,1
2,22.1,Chest discomfort,17047822,1
3,22.1,Erythema,17047822,1
4,22.1,Flushing,17047822,1
5,22.1,Dyspnoea,17047822,1
6,22.1,Off label use,17047822,6
0,22.1,Hernia,17047838,6
0,22.1,Oxygen saturation abnormal,17047865,1
1,22.1,Flushing,17047865,1
2,22.1,Vomiting,17047865,1
3,22.1,Chest discomfort,17047865,1
4,22.1,Immediate post-injection reaction,17047865,1
0,22.1,Haemorrhage,17047877,6
0,22.1,Intestinal perforation,17047878,5
0,22.1,Cardiac disorder,17047881,6
1,22.1,Prostate cancer,17047881,6
2,22.1,Death,17047881,5
3,22.1,Hepatic failure,17047881,6
0,22.1,Death,17047886,5
0,22.1,Chest discomfort,17047888,1
1,22.1,Dyspnoea,17047888,1
0,22.1,Death,17047890,5
0,22.1,Death,17047893,5
0,22.1,Oxygen saturation decreased,17047895,1
1,22.1,Chest discomfort,17047895,1
2,22.1,Flushing,17047895,1
3,22.1,Vomiting,17047895,1
0,22.1,Death,17047896,5
0,22.1,Myocardial infarction,17047912,1
0,22.1,Gastritis,17047970,6
1,22.1,Abdominal pain upper,17047970,6
2,22.1,Product use in unapproved indication,17047970,6
0,22.1,Neoplasm,17047977,6
1,22.1,Drug resistance,17047977,6
2,22.1,Alopecia,17047977,6
3,22.1,Asthenia,17047977,6
4,22.1,Mediastinum neoplasm,17047977,6
5,22.1,Drug resistance,17047977,6
6,22.1,Neoplasm,17047977,6
0,22.1,Pneumonitis,17048008,1
0,22.1,Femur fracture,17048023,2
1,22.1,Fall,17048023,2
0,22.1,Alopecia,17048044,3
1,22.1,Hair disorder,17048044,3
2,22.1,Hair texture abnormal,17048044,3
3,22.1,Hair colour changes,17048044,3
0,22.1,Hair disorder,17048064,3
1,22.1,Alopecia,17048064,3
2,22.1,Madarosis,17048064,3
3,22.1,Hair colour changes,17048064,3
4,22.1,Hair texture abnormal,17048064,3
0,22.1,Hypotension,17048096,6
1,22.1,Oxygen saturation decreased,17048096,6
2,22.1,Hyperhidrosis,17048096,6
3,22.1,Dyspnoea,17048096,6
4,22.1,Flushing,17048096,6
0,22.1,Hepatitis B reactivation,17048104,6
1,22.1,Acute hepatic failure,17048104,6
0,22.1,Headache,17048106,6
1,22.1,Product dose omission,17048106,6
0,22.1,Fatigue,17048107,6
0,22.1,Dysphagia,17048109,1
0,22.1,Neuropathy peripheral,17048111,6
0,22.1,Fluid retention,17048128,2
0,22.1,White blood cell count decreased,17048143,6
0,22.1,Neoplasm progression,17048151,6
0,22.1,Malaise,17048152,6
0,22.1,Atrial fibrillation,17048153,6
1,22.1,Somnolence,17048153,6
2,22.1,Dizziness,17048153,6
3,22.1,Fatigue,17048153,6
4,22.1,Decreased appetite,17048153,6
5,22.1,Peripheral swelling,17048153,6
0,22.1,Weight decreased,17048155,3
1,22.1,Somnolence,17048155,6
2,22.1,White blood cell count decreased,17048155,6
3,22.1,Skin lesion,17048155,6
4,22.1,Fatigue,17048155,6
0,22.1,White blood cell count decreased,17048176,6
0,22.1,Fatigue,17048180,6
1,22.1,Vomiting,17048180,6
2,22.1,Product dose omission,17048180,6
0,22.1,Metastases to central nervous system,17048205,6
0,22.1,Bone marrow failure,17048219,1
0,22.1,Blood pressure increased,17048236,1
1,22.1,Chest discomfort,17048236,1
2,22.1,Erythema,17048236,1
3,22.1,Pruritus,17048236,1
0,22.1,Dysphonia,17048245,1
1,22.1,Muscle twitching,17048245,1
2,22.1,Cough,17048245,1
3,22.1,Swelling of eyelid,17048245,1
0,22.1,Osteonecrosis of jaw,17048251,4
1,22.1,Chronic sinusitis,17048251,6
2,22.1,Acute sinusitis,17048251,4
3,22.1,Condition aggravated,17048251,6
0,22.1,Dyspnoea,17048255,
1,22.1,Epistaxis,17048255,
0,22.1,Hot flush,17048260,1
1,22.1,Gastroenteritis,17048260,1
0,22.1,Pleural effusion,17048270,
1,22.1,Pericardial effusion,17048270,
0,22.1,Off label use,17048324,6
1,22.1,Product use issue,17048324,6
2,22.1,White blood cell count decreased,17048324,6
0,22.1,Disease progression,17048343,
0,22.1,Myocardial infarction,17048355,5
0,22.1,Pleural effusion,17048358,6
0,22.1,Disease progression,17048369,
0,22.1,Death,17048379,
0,22.1,Neoplasm progression,17048381,6
0,22.1,Pain in extremity,17048389,6
1,22.1,Arthralgia,17048389,6
2,22.1,Osteopenia,17048389,6
3,22.1,Neoplasm progression,17048389,6
0,22.1,Malignant neoplasm progression,17048394,6
0,22.1,Erythema,17048418,
1,22.1,Skin exfoliation,17048418,
0,22.1,Venous thrombosis,17048421,1
1,22.1,Axillary vein thrombosis,17048421,1
2,22.1,Subclavian vein thrombosis,17048421,1
3,22.1,Aplasia pure red cell,17048421,3
4,22.1,Febrile neutropenia,17048421,1
5,22.1,Squamous cell carcinoma,17048421,1
0,22.1,Stevens-Johnson syndrome,17048427,
0,22.1,Hypoaesthesia,17048439,1
1,22.1,Death,17048439,5
2,22.1,Weight decreased,17048439,6
3,22.1,Dysphonia,17048439,3
0,22.1,Neoplasm progression,17048467,6
0,22.1,Mouth haemorrhage,17048471,6
1,22.1,Gingival bleeding,17048471,6
2,22.1,White blood cell count decreased,17048471,6
3,22.1,Oropharyngeal pain,17048471,6
4,22.1,Pruritus,17048471,6
5,22.1,Platelet count decreased,17048471,6
6,22.1,Decreased appetite,17048471,6
0,22.1,Breast pain,17048480,6
1,22.1,Dyspnoea,17048480,6
0,22.1,Blood creatinine increased,17048494,1
1,22.1,Abdominal pain upper,17048494,1
2,22.1,Prostatic specific antigen increased,17048494,1
3,22.1,Renal failure,17048494,1
4,22.1,Decreased appetite,17048494,6
0,22.1,Hypotension,17048511,1
1,22.1,Anaphylactic reaction,17048511,1
2,22.1,Erythema,17048511,1
3,22.1,Tachycardia,17048511,1
4,22.1,Hypersensitivity,17048511,1
5,22.1,Bronchospasm,17048511,1
0,22.1,Metabolic acidosis,17048520,1
1,22.1,Cardio-respiratory arrest,17048520,1
2,22.1,Acute kidney injury,17048520,1
3,22.1,Hyperkalaemia,17048520,1
4,22.1,Drug interaction,17048520,6
0,22.1,Pulmonary toxicity,17048547,6
0,22.1,Purulence,17048557,1
1,22.1,Induration,17048557,1
0,22.1,Pneumonia,17048584,5
0,22.1,Hospitalisation,17048586,
0,22.1,Death,17048601,
0,22.1,Drug ineffective,17048648,3
1,22.1,Phlebitis,17048648,3
2,22.1,Dyspnoea,17048648,6
3,22.1,Pulmonary embolism,17048648,2
4,22.1,Deep vein thrombosis,17048648,2
0,22.1,Thyroxine decreased,17048673,6
1,22.1,Blood thyroid stimulating hormone increased,17048673,6
0,22.1,Blood pressure increased,17048737,1
1,22.1,Hypoaesthesia,17048737,1
2,22.1,Muscle spasms,17048737,1
3,22.1,Palpitations,17048737,1
4,22.1,Blood creatine abnormal,17048737,1
5,22.1,Blood magnesium abnormal,17048737,1
6,22.1,Tachycardia,17048737,1
7,22.1,Paraesthesia,17048737,1
8,22.1,Dysarthria,17048737,1
9,22.1,Tongue disorder,17048737,1
0,22.1,Death,17048762,5
1,22.1,Neoplasm progression,17048762,6
0,22.1,Acute myeloid leukaemia,17048779,3
0,22.1,Malignant neoplasm progression,17048821,6
1,22.1,Splenomegaly,17048821,6
2,22.1,Psoriasis,17048821,2
3,22.1,Organising pneumonia,17048821,6
4,22.1,Melanocytic naevus,17048821,6
5,22.1,Pigmentation disorder,17048821,6
6,22.1,Post procedural erythema,17048821,6
7,22.1,Radiation pneumonitis,17048821,1
8,22.1,Skin mass,17048821,6
0,22.1,Anaphylactic reaction,17048822,
0,22.1,Vertigo,17048838,1
0,22.1,Dyspnoea,17048917,3
0,22.1,Anxiety,17048926,6
1,22.1,Alopecia,17048926,2
2,22.1,Psychological trauma,17048926,6
3,22.1,Emotional distress,17048926,6
4,22.1,Pain,17048926,6
5,22.1,Impaired quality of life,17048926,6
0,22.1,Psychological trauma,17048928,6
1,22.1,Alopecia,17048928,3
0,22.1,Anxiety,17048938,6
1,22.1,Alopecia,17048938,3
2,22.1,Pain,17048938,6
3,22.1,Impaired quality of life,17048938,6
4,22.1,Emotional distress,17048938,6
0,22.1,Psychological trauma,17048943,6
1,22.1,Alopecia,17048943,2
0,22.1,Psychological trauma,17048949,6
1,22.1,Emotional distress,17048949,6
2,22.1,Alopecia,17048949,2
3,22.1,Anxiety,17048949,6
0,22.1,Alopecia,17048959,2
1,22.1,Emotional distress,17048959,6
2,22.1,Anxiety,17048959,6
0,22.1,Renal injury,17048972,
0,22.1,Alopecia,17048975,2
1,22.1,Anxiety,17048975,6
2,22.1,Emotional distress,17048975,6
3,22.1,Psychological trauma,17048975,6
0,22.1,Haemorrhage,17049005,5
1,22.1,Shock haemorrhagic,17049005,5
0,22.1,Generalised oedema,17049010,1
1,22.1,Pneumonia,17049010,1
0,22.1,Shock,17049064,2
0,22.1,Shock,17049074,2
0,22.1,Interstitial lung disease,17049094,1
0,22.1,Neoplasm progression,17049095,6
1,22.1,Skin reaction,17049095,6
2,22.1,Diarrhoea,17049095,6
3,22.1,Neuropathy peripheral,17049095,6
0,22.1,Dyspepsia,17049102,1
1,22.1,Mucosal haemorrhage,17049102,6
2,22.1,Pain,17049102,6
3,22.1,Syncope,17049102,1
4,22.1,Thrombosis,17049102,6
5,22.1,Hypertension,17049102,6
6,22.1,Neoplasm progression,17049102,6
7,22.1,Clostridium difficile infection,17049102,6
8,22.1,Vomiting,17049102,3
9,22.1,Cough,17049102,3
10,22.1,Muscular weakness,17049102,6
11,22.1,Fatigue,17049102,3
12,22.1,Pneumonia,17049102,1
13,22.1,Nausea,17049102,3
14,22.1,Pleural effusion,17049102,6
15,22.1,Acute respiratory failure,17049102,6
16,22.1,Constipation,17049102,3
0,22.1,Pancreatitis,17049113,6
1,22.1,Hepatic function abnormal,17049113,1
2,22.1,Panic disorder,17049113,6
3,22.1,Off label use,17049113,6
4,22.1,Polymyalgia rheumatica,17049113,1
5,22.1,Hypothyroidism,17049113,1
6,22.1,Cholangitis sclerosing,17049113,6
7,22.1,Oculomucocutaneous syndrome,17049113,1
0,22.1,Death,17049121,5
0,22.1,Myocardial infarction,17049122,6
0,22.1,Jaundice,17049192,5
1,22.1,Blood glucose increased,17049192,3
2,22.1,Hepatic enzyme increased,17049192,5
3,22.1,Drug ineffective,17049192,3
4,22.1,Hepatic function abnormal,17049192,5
0,22.1,Haematochezia,17049198,6
0,22.1,Hypertension,17049211,3
0,22.1,Agranulocytosis,17049226,1
1,22.1,Neutropenia,17049226,1
0,22.1,Malignant neoplasm progression,17049227,6
0,22.1,Death,17049229,5
0,22.1,Radiation pneumonitis,17049233,6
0,22.1,Atypical haemolytic uraemic syndrome,17049252,1
0,22.1,Toxicity to various agents,17049281,6
1,22.1,Neoplasm progression,17049281,6
0,22.1,Neoplasm progression,17049282,6
1,22.1,Death,17049282,5
0,22.1,Neoplasm progression,17049287,6
1,22.1,Death,17049287,5
0,22.1,Death,17049353,5
0,22.1,Epistaxis,17049357,1
0,22.1,Death,17049362,
0,22.1,Breast cancer,17049367,5
0,22.1,Adrenal insufficiency,17049368,3
0,22.1,Urinary tract obstruction,17049371,3
0,22.1,Superinfection bacterial,17049374,2
0,22.1,Diarrhoea,17049392,2
0,22.1,Disease progression,17049394,6
1,22.1,Drug resistance,17049394,6
0,22.1,Death,17049397,
0,22.1,Lung opacity,17049398,3
0,22.1,Weight decreased,17049399,2
1,22.1,Interstitial lung disease,17049399,1
2,22.1,Cough,17049399,6
3,22.1,Decreased appetite,17049399,2
0,22.1,Death,17049449,
0,22.1,Dysphagia,17049483,6
1,22.1,Rash,17049483,6
2,22.1,Malignant neoplasm progression,17049483,6
3,22.1,Pruritus,17049483,6
4,22.1,Metastases to central nervous system,17049483,6
5,22.1,Decreased appetite,17049483,6
0,22.1,Diarrhoea haemorrhagic,17049484,
0,22.1,Hyperplasia of thymic epithelium,17049490,6
0,22.1,Febrile neutropenia,17049504,3
1,22.1,Pneumonia aspiration,17049504,5
2,22.1,Enteritis infectious,17049504,3
3,22.1,Haemoptysis,17049504,1
0,22.1,Hyperthyroidism,17049528,1
1,22.1,Alanine aminotransferase decreased,17049528,3
2,22.1,Lipase increased,17049528,3
3,22.1,Aspartate aminotransferase decreased,17049528,3
4,22.1,Drug intolerance,17049528,6
5,22.1,Central venous catheterisation,17049528,6
6,22.1,Uraemic gastropathy,17049528,6
7,22.1,Hypothyroidism,17049528,1
8,22.1,Blood fibrinogen increased,17049528,3
9,22.1,Gastroenteritis,17049528,6
10,22.1,Otitis externa,17049528,6
11,22.1,Acute kidney injury,17049528,1
12,22.1,Amylase increased,17049528,3
0,22.1,Overdose,17049536,1
0,22.1,Carbohydrate antigen 15-3 increased,17049554,3
1,22.1,Haematotoxicity,17049554,6
2,22.1,Anaemia,17049554,2
3,22.1,Neutrophil count decreased,17049554,2
0,22.1,Bronchospasm,17049556,
1,22.1,Off label use,17049556,
0,22.1,Prescribed overdose,17049569,2
1,22.1,Sinus arrest,17049569,2
2,22.1,Urine output decreased,17049569,6
3,22.1,Hyperkalaemia,17049569,2
4,22.1,Acute kidney injury,17049569,2
5,22.1,Product prescribing error,17049569,2
6,22.1,Rhythm idioventricular,17049569,2
0,22.1,Death,17049573,5
0,22.1,Nausea,17049591,3
1,22.1,Myalgia,17049591,3
2,22.1,Arthralgia,17049591,3
3,22.1,Dyspnoea,17049591,3
4,22.1,Tachycardia,17049591,3
5,22.1,Back pain,17049591,1
6,22.1,Chest discomfort,17049591,3
0,22.1,Off label use,17049601,6
1,22.1,Decreased appetite,17049601,3
2,22.1,Abnormal weight gain,17049601,3
3,22.1,Incorrect dose administered,17049601,6
0,22.1,Febrile neutropenia,17049603,6
1,22.1,Hypersensitivity,17049603,4
0,22.1,Lung neoplasm malignant,17049615,6
0,22.1,Malignant neoplasm progression,17049632,6
1,22.1,Off label use,17049632,6
2,22.1,Product use in unapproved indication,17049632,6
0,22.1,Refractory cytopenia with unilineage dysplasia,17049645,6
0,22.1,Asthenia,17049665,6
1,22.1,Odynophagia,17049665,6
2,22.1,Mucosal inflammation,17049665,6
3,22.1,Neutropenia,17049665,6
0,22.1,Appendicitis perforated,17049675,1
0,22.1,Diarrhoea,17049698,6
1,22.1,Blister,17049698,6
2,22.1,Pain,17049698,6
3,22.1,Fatigue,17049698,6
4,22.1,Blood pressure increased,17049698,6
5,22.1,Decreased appetite,17049698,6
0,22.1,Wrong technique in product usage process,17049699,
1,22.1,Device connection issue,17049699,
2,22.1,Intercepted product preparation error,17049699,
0,22.1,Somnolence,17049703,1
1,22.1,Off label use,17049703,6
2,22.1,Product use in unapproved indication,17049703,6
3,22.1,Chest discomfort,17049703,1
4,22.1,Flushing,17049703,1
5,22.1,Dyspnoea,17049703,1
0,22.1,Catheter site cellulitis,17049711,1
0,22.1,Pneumonitis,17049713,2
1,22.1,Cough,17049713,2
0,22.1,Atrial fibrillation,17049719,6
0,22.1,Chest pain,17049743,1
0,22.1,Hepatic cirrhosis,17049745,6
1,22.1,Chronic hepatitis,17049745,6
0,22.1,Visual impairment,17049756,2
1,22.1,Drug interaction,17049756,6
2,22.1,Ataxia,17049756,2
3,22.1,Chorea,17049756,2
4,22.1,Photophobia,17049756,2
5,22.1,Memory impairment,17049756,2
6,22.1,Headache,17049756,2
7,22.1,Coordination abnormal,17049756,2
8,22.1,Dyskinesia,17049756,2
9,22.1,Toxicity to various agents,17049756,2
10,22.1,Confusional state,17049756,2
0,22.1,Ejection fraction decreased,17049800,6
0,22.1,Anaemia,17049810,6
1,22.1,Cytopenia,17049810,6
2,22.1,Thrombocytopenia,17049810,6
3,22.1,Stomatitis,17049810,6
0,22.1,Drug interaction,17049830,5
1,22.1,Contraindicated product prescribed,17049830,5
2,22.1,Pancytopenia,17049830,5
3,22.1,Multiple organ dysfunction syndrome,17049830,5
4,22.1,Mucosal inflammation,17049830,5
5,22.1,Respiratory failure,17049830,5
0,22.1,Disease progression,17049849,6
0,22.1,Pain,17049850,2
1,22.1,Muscle rigidity,17049850,2
0,22.1,Hypoaesthesia,17049854,6
1,22.1,Lacrimation increased,17049854,3
2,22.1,Dry skin,17049854,3
3,22.1,Pigmentation disorder,17049854,3
4,22.1,Madarosis,17049854,3
5,22.1,Onychoclasis,17049854,3
6,22.1,Polyneuropathy,17049854,6
7,22.1,Sensory disturbance,17049854,6
8,22.1,Rhinitis,17049854,3
0,22.1,Agranulocytosis,17049867,1
0,22.1,Myelodysplastic syndrome,17049870,3
1,22.1,Second primary malignancy,17049870,3
0,22.1,Sudden death,17049874,5
1,22.1,Neutropenia,17049874,6
0,22.1,Death,17049876,5
0,22.1,Device related thrombosis,17049881,3
1,22.1,Hypertension,17049881,3
2,22.1,Paraesthesia,17049881,3
0,22.1,Arthralgia,17049883,6
1,22.1,Back pain,17049883,6
2,22.1,Dyspnoea,17049883,6
3,22.1,Chest pain,17049883,6
0,22.1,Cough,17049888,6
1,22.1,Throat irritation,17049888,6
2,22.1,Hypertension,17049888,6
3,22.1,Chest pain,17049888,6
4,22.1,Erythema,17049888,6
5,22.1,Pruritus,17049888,6
6,22.1,Dyspnoea,17049888,6
7,22.1,Wheezing,17049888,6
8,22.1,Back pain,17049888,6
0,22.1,Chest pain,17049890,6
1,22.1,Dyspnoea,17049890,6
2,22.1,Erythema,17049890,6
3,22.1,Wheezing,17049890,6
4,22.1,Cough,17049890,6
5,22.1,Pruritus,17049890,6
6,22.1,Throat irritation,17049890,6
7,22.1,Back pain,17049890,6
8,22.1,Hypertension,17049890,6
0,22.1,Disease progression,17049927,6
0,22.1,Disease progression,17049928,6
0,22.1,Bronchospasm,17049934,1
0,22.1,Disease progression,17049935,6
0,22.1,Disease progression,17049940,6
0,22.1,Disease progression,17049950,6
0,22.1,Fatigue,17049972,6
0,22.1,Alopecia,17050003,6
1,22.1,Skin disorder,17050003,6
0,22.1,Erythema multiforme,17050033,2
1,22.1,Arrhythmia,17050033,1
2,22.1,Dyspnoea,17050033,1
3,22.1,Malaise,17050033,2
0,22.1,Hypersensitivity,17050067,6
0,22.1,White blood cell count decreased,17050081,6
1,22.1,Fatigue,17050081,6
2,22.1,Hepatic failure,17050081,5
3,22.1,Neoplasm progression,17050081,5
0,22.1,Pruritus,17050091,6
1,22.1,Abdominal pain upper,17050091,5
2,22.1,Neoplasm progression,17050091,6
0,22.1,Fatigue,17050102,6
1,22.1,Dysphagia,17050102,6
2,22.1,Asthenia,17050102,6
3,22.1,Off label use,17050102,6
0,22.1,Chills,17050159,1
1,22.1,Lower respiratory tract infection,17050159,1
2,22.1,Cellulitis,17050159,1
3,22.1,Lower respiratory tract infection,17050159,1
4,22.1,Peripheral swelling,17050159,6
5,22.1,Dyspnoea,17050159,1
6,22.1,Lower respiratory tract infection,17050159,1
7,22.1,Neutrophil count decreased,17050159,1
8,22.1,Sepsis,17050159,1
9,22.1,Lung consolidation,17050159,6
10,22.1,Pain in extremity,17050159,1
11,22.1,Fatigue,17050159,3
12,22.1,Blood pressure decreased,17050159,1
13,22.1,Streptococcus test positive,17050159,6
14,22.1,Confusional state,17050159,1
15,22.1,Vomiting,17050159,1
16,22.1,Arthralgia,17050159,3
17,22.1,Pneumonia,17050159,1
18,22.1,Lethargy,17050159,6
19,22.1,Pneumonia,17050159,1
20,22.1,Pyrexia,17050159,1
21,22.1,Neutropenia,17050159,1
0,22.1,Death,17050215,5
0,22.1,Nephropathy toxic,17050268,6
0,22.1,Neutropenia,17050269,6
1,22.1,Nephropathy toxic,17050269,6
0,22.1,Neutrophil count decreased,17050294,1
0,22.1,Splenic abscess,17050307,6
1,22.1,Liver abscess,17050307,6
0,22.1,Metastases to lung,17050319,6
1,22.1,Metastases to liver,17050319,6
2,22.1,Metastases to skin,17050319,6
3,22.1,Hypophagia,17050319,6
4,22.1,Malignant neoplasm progression,17050319,6
5,22.1,Breast cancer,17050319,6
6,22.1,Metastases to bone,17050319,6
7,22.1,Pain,17050319,6
8,22.1,Weight decreased,17050319,6
0,22.1,Thrombocytopenia,17050348,6
1,22.1,Aspartate aminotransferase increased,17050348,6
2,22.1,Mental status changes,17050348,6
3,22.1,Confusional state,17050348,6
4,22.1,Respiratory failure,17050348,5
5,22.1,Dehydration,17050348,6
6,22.1,Neutrophil count abnormal,17050348,6
0,22.1,Gastroenteritis,17050350,1
0,22.1,Infusion site urticaria,17050355,1
1,22.1,Flushing,17050355,1
2,22.1,Infusion site erythema,17050355,1
3,22.1,Swelling face,17050355,1
4,22.1,Urticaria,17050355,1
5,22.1,Periorbital oedema,17050355,1
6,22.1,Off label use,17050355,6
7,22.1,Product use in unapproved indication,17050355,6
8,22.1,Erythema,17050355,1
9,22.1,Feeling hot,17050355,1
10,22.1,Infusion site pain,17050355,1
11,22.1,Pruritus,17050355,1
0,22.1,Death,17050356,5
0,22.1,Death,17050358,5
0,22.1,Peripheral embolism,17050365,4
1,22.1,Foot amputation,17050365,4
0,22.1,Susac^s syndrome,17050372,6
1,22.1,Cholangitis,17050372,6
0,22.1,Confusional state,17050376,3
1,22.1,Colon cancer metastatic,17050376,6
2,22.1,Tumour obstruction,17050376,3
3,22.1,Product use in unapproved indication,17050376,6
0,22.1,Thrombocytopenia,17050396,1
1,22.1,Febrile neutropenia,17050396,1
2,22.1,Anaemia,17050396,1
0,22.1,Femur fracture,17050404,2
1,22.1,Pneumonia,17050404,1
2,22.1,Interstitial lung disease,17050404,2
3,22.1,Gastric ulcer,17050404,1
4,22.1,Fall,17050404,6
0,22.1,Malignant ascites,17050405,6
1,22.1,Diarrhoea,17050405,3
2,22.1,Blood chloride decreased,17050405,6
3,22.1,Drug intolerance,17050405,6
4,22.1,Metastases to bone,17050405,6
5,22.1,Muscle spasms,17050405,6
6,22.1,Red blood cell count decreased,17050405,6
7,22.1,Metastases to spine,17050405,6
8,22.1,Neutrophil count decreased,17050405,6
9,22.1,Hypokinesia,17050405,6
10,22.1,Mobility decreased,17050405,6
11,22.1,Abdominal discomfort,17050405,6
12,22.1,Platelet count decreased,17050405,6
13,22.1,Mean cell volume increased,17050405,6
14,22.1,Feeling abnormal,17050405,6
15,22.1,Haematocrit decreased,17050405,6
16,22.1,Breast cancer metastatic,17050405,5
17,22.1,Malignant neoplasm progression,17050405,5
18,22.1,Metastases to stomach,17050405,6
19,22.1,Eating disorder,17050405,6
20,22.1,Drug ineffective,17050405,6
21,22.1,Vomiting,17050405,3
22,22.1,Malaise,17050405,6
23,22.1,Fatigue,17050405,6
24,22.1,Liver disorder,17050405,6
25,22.1,Inflammation,17050405,6
26,22.1,Depressed mood,17050405,6
27,22.1,Nausea,17050405,6
28,22.1,Haemoglobin decreased,17050405,6
29,22.1,Dizziness,17050405,6
0,22.1,Pericarditis,17050406,1
0,22.1,Pneumonia staphylococcal,17050419,6
0,22.1,Metastases to breast,17050551,6
1,22.1,Malignant neoplasm progression,17050551,6
2,22.1,Polyneuropathy,17050551,6
0,22.1,Febrile neutropenia,17050586,1
1,22.1,Thrombocytopenia,17050586,1
2,22.1,Neutropenia,17050586,1
3,22.1,Anaemia,17050586,1
0,22.1,Bone marrow failure,17050592,6
0,22.1,Disease recurrence,17050593,6
1,22.1,Bone marrow toxicity,17050593,6
2,22.1,Toxicity to various agents,17050593,6
3,22.1,Therapy partial responder,17050593,6
4,22.1,Disease recurrence,17050593,6
5,22.1,Metastases to lung,17050593,6
6,22.1,Anaemia,17050593,6
7,22.1,Disease recurrence,17050593,6
8,22.1,Metastases to lymph nodes,17050593,6
9,22.1,Malignant neoplasm progression,17050593,6
10,22.1,Metastases to lymph nodes,17050593,6
11,22.1,Metastases to lymph nodes,17050593,6
12,22.1,Metastasis,17050593,6
0,22.1,Transaminases increased,17050712,1
1,22.1,Breast cancer recurrent,17050712,6
0,22.1,Pyrexia,17050735,3
1,22.1,Cardiac arrest,17050735,5
2,22.1,Blood pressure decreased,17050735,5
3,22.1,Febrile neutropenia,17050735,3
4,22.1,Myocardial infarction,17050735,5
5,22.1,Dyspnoea,17050735,5
6,22.1,Diarrhoea,17050735,6
0,22.1,Pneumonia,17050738,5
0,22.1,Metastases to central nervous system,17050793,6
1,22.1,Breast cancer recurrent,17050793,6
2,22.1,Cardiac dysfunction,17050793,6
0,22.1,Disease progression,17050804,5
0,22.1,Pneumothorax,17050814,6
0,22.1,No adverse event,17050874,6
0,22.1,Bone pain,17050973,6
0,22.1,Malignant neoplasm progression,17051026,5
1,22.1,Generalised oedema,17051026,5
2,22.1,Fluid retention,17051026,5
0,22.1,Death,17051048,5
0,22.1,Prescribed underdose,17051108,6
0,22.1,Renal impairment,17051119,1
0,22.1,Skin disorder,17051123,1
1,22.1,Lung opacity,17051123,2
0,22.1,Papilloedema,17051127,2
1,22.1,Optic neuritis,17051127,2
0,22.1,Diabetes mellitus,17051209,2
0,22.1,Hypokalaemia,17051220,6
1,22.1,Hypoxia,17051220,6
2,22.1,Hypomagnesaemia,17051220,6
3,22.1,Cough,17051220,6
4,22.1,Small intestinal obstruction,17051220,6
5,22.1,Hypoalbuminaemia,17051220,6
6,22.1,Respiratory failure,17051220,5
7,22.1,Acute respiratory distress syndrome,17051220,5
8,22.1,Pyrexia,17051220,6
0,22.1,Product use in unapproved indication,17051269,6
1,22.1,Drug intolerance,17051269,6
0,22.1,Myasthenia gravis,17051305,6
1,22.1,Eyelid ptosis,17051305,3
0,22.1,Pneumonia aspiration,17051318,5
1,22.1,Off label use,17051318,6
2,22.1,Intentional product use issue,17051318,6
0,22.1,Hypersensitivity,17051377,6
1,22.1,Hypotension,17051377,6
2,22.1,Pyrexia,17051377,6
0,22.1,Hepatic failure,17051532,2
1,22.1,Duplicate therapy error,17051532,1
2,22.1,Thrombocytopenia,17051532,2
3,22.1,Overdose,17051532,1
0,22.1,Mucosal inflammation,17051542,1
0,22.1,Dyspnoea,17051547,1
1,22.1,Oxygen saturation decreased,17051547,1
2,22.1,Hypertension,17051547,1
3,22.1,Weight decreased,17051547,1
0,22.1,Protein urine,17051551,1
1,22.1,Platelet count decreased,17051551,1
2,22.1,Stomatitis,17051551,1
3,22.1,Epistaxis,17051551,1
4,22.1,Skin disorder,17051551,1
5,22.1,Neuropathy peripheral,17051551,1
0,22.1,Prescribed underdose,17051566,6
1,22.1,Cancer pain,17051566,3
0,22.1,Erythema,17051587,6
1,22.1,Skin exfoliation,17051587,6
2,22.1,Asthma,17051587,6
3,22.1,Anaemia,17051587,6
4,22.1,Skin toxicity,17051587,6
5,22.1,Febrile neutropenia,17051587,6
6,22.1,Heart valve incompetence,17051587,6
7,22.1,Hyperglycaemia,17051587,6
8,22.1,Altered state of consciousness,17051587,6
9,22.1,Coagulopathy,17051587,6
10,22.1,Toxic epidermal necrolysis,17051587,6
11,22.1,Thrombocytopenia,17051587,6
12,22.1,Overdose,17051587,5
13,22.1,Polyneuropathy,17051587,3
14,22.1,Lymphadenopathy,17051587,6
15,22.1,Hepatic failure,17051587,5
16,22.1,Dandy-Walker syndrome,17051587,6
17,22.1,Hepatic steatosis,17051587,6
18,22.1,Menorrhagia,17051587,6
19,22.1,Sopor,17051587,6
20,22.1,Hypertension,17051587,6
21,22.1,Uterine leiomyoma,17051587,6
0,22.1,Pulmonary embolism,17051631,5
1,22.1,Pneumonia,17051631,5
2,22.1,Toxic epidermal necrolysis,17051631,5
3,22.1,Radiation pneumonitis,17051631,5
0,22.1,Pneumonia,17051645,1
0,22.1,Systemic inflammatory response syndrome,17051655,2
1,22.1,Nephropathy toxic,17051655,2
2,22.1,Cardiotoxicity,17051655,2
0,22.1,Dehydration,17051660,6
1,22.1,Hypoaesthesia,17051660,6
2,22.1,Cerebral infarction,17051660,4
3,22.1,Dementia,17051660,6
0,22.1,Rhabdomyolysis,17051671,1
0,22.1,Oedema peripheral,17051676,2
1,22.1,Delirium,17051676,1
2,22.1,Breast cancer recurrent,17051676,6
3,22.1,Malaise,17051676,2
4,22.1,Hot flush,17051676,2
5,22.1,Balance disorder,17051676,2
6,22.1,Insomnia,17051676,2
7,22.1,Pain,17051676,2
8,22.1,Neuropathy peripheral,17051676,2
9,22.1,Blood cholesterol increased,17051676,2
10,22.1,Joint stiffness,17051676,2
11,22.1,Muscle spasms,17051676,2
12,22.1,Gait disturbance,17051676,2
13,22.1,Confusional state,17051676,2
14,22.1,Hallucination,17051676,2
15,22.1,Speech disorder,17051676,2
16,22.1,Polyneuropathy,17051676,6
17,22.1,Hypoaesthesia,17051676,2
18,22.1,Conjunctivitis,17051676,6
19,22.1,Myalgia,17051676,2
0,22.1,Dyspnoea,17051705,3
0,22.1,Death,17051736,5
0,22.1,Syncope,17051744,6
1,22.1,Loss of consciousness,17051744,6
2,22.1,Dizziness,17051744,6
0,22.1,Non-small cell lung cancer stage IIIA,17051745,5
1,22.1,Off label use,17051745,6
2,22.1,Intentional product use issue,17051745,6
0,22.1,Libido decreased,17051750,6
1,22.1,Menopausal symptoms,17051750,6
2,22.1,Sexual dysfunction,17051750,6
3,22.1,Anorgasmia,17051750,6
0,22.1,Hormone-refractory prostate cancer,17051758,6
1,22.1,Condition aggravated,17051758,6
0,22.1,Platelet count decreased,17051775,1
0,22.1,Death,17051837,5
0,22.1,Upper gastrointestinal haemorrhage,17051847,1
0,22.1,Transitional cell cancer of the renal pelvis and ureter,17051850,2
0,22.1,Plasma cell myeloma,17051888,5
0,22.1,Osteomyelitis,17052138,2
1,22.1,Intervertebral discitis,17052138,2
2,22.1,Mycobacterial infection,17052138,2
0,22.1,Diarrhoea,17052158,6
1,22.1,Cerebrovascular accident,17052158,6
0,22.1,Decreased appetite,17052175,6
1,22.1,Dehydration,17052175,6
0,22.1,Gastrointestinal toxicity,17052189,3
0,22.1,Pyrexia,17052247,1
1,22.1,Blood bilirubin increased,17052247,6
2,22.1,Basedow^s disease,17052247,3
3,22.1,Jaundice,17052247,6
4,22.1,Tumour embolism,17052247,6
5,22.1,Malaise,17052247,6
6,22.1,Fibrin D dimer decreased,17052247,6
0,22.1,Disease progression,17052257,
0,22.1,Cough,17052320,6
1,22.1,Haemorrhage,17052320,3
2,22.1,Dyspnoea,17052320,6
3,22.1,Thrombocytopenia,17052320,6
4,22.1,Visual impairment,17052320,6
5,22.1,Fatigue,17052320,1
6,22.1,Neutropenia,17052320,3
7,22.1,Rash,17052320,6
8,22.1,Dry mouth,17052320,6
9,22.1,Hypertension,17052320,3
10,22.1,Dysgeusia,17052320,3
0,22.1,Off label use,17052328,1
1,22.1,Product use in unapproved indication,17052328,1
2,22.1,Dyspnoea,17052328,1
3,22.1,Eye swelling,17052328,1
4,22.1,Hypotension,17052328,1
5,22.1,Hypersensitivity,17052328,1
0,22.1,Dysphonia,17052404,
0,22.1,Renal impairment,17052411,6
1,22.1,Blood creatinine increased,17052411,6
0,22.1,Infection,17052417,
0,22.1,Liver disorder,17052425,
0,22.1,Liver disorder,17052432,
0,22.1,Contusion,17052471,3
1,22.1,Nausea,17052471,3
2,22.1,Pain in extremity,17052471,3
3,22.1,Pyrexia,17052471,3
4,22.1,Arthralgia,17052471,3
5,22.1,Decreased appetite,17052471,3
6,22.1,Dysgeusia,17052471,3
7,22.1,Sepsis,17052471,3
8,22.1,Urinary tract infection,17052471,3
9,22.1,Abdominal pain upper,17052471,3
10,22.1,Dysuria,17052471,3
11,22.1,Hyperhidrosis,17052471,3
12,22.1,Leukocytosis,17052471,3
13,22.1,Peripheral swelling,17052471,3
14,22.1,Bone pain,17052471,3
15,22.1,Hepatic steatosis,17052471,3
16,22.1,Joint swelling,17052471,3
17,22.1,Mass,17052471,3
18,22.1,Sinus tachycardia,17052471,3
19,22.1,Dry skin,17052471,3
20,22.1,Myalgia,17052471,3
21,22.1,Pollakiuria,17052471,3
22,22.1,Urine odour abnormal,17052471,3
23,22.1,Accidental overdose,17052471,3
0,22.1,Pleural effusion,17052484,6
1,22.1,Dyspnoea,17052484,6
2,22.1,Polyneuropathy,17052484,6
3,22.1,Neoplasm progression,17052484,6
0,22.1,Pneumonia,17052492,
0,22.1,Chest discomfort,17052495,1
1,22.1,Flushing,17052495,1
2,22.1,Dyspnoea,17052495,1
3,22.1,Nausea,17052495,1
4,22.1,Respiratory distress,17052495,1
5,22.1,Off label use,17052495,1
0,22.1,Off label use,17052498,6
1,22.1,Dyspnoea,17052498,1
2,22.1,Somnolence,17052498,1
3,22.1,Chest discomfort,17052498,1
4,22.1,Flushing,17052498,1
5,22.1,Product use in unapproved indication,17052498,6
0,22.1,Respiratory distress,17052499,1
1,22.1,Abdominal discomfort,17052499,1
2,22.1,Flushing,17052499,1
0,22.1,Lip swelling,17052501,3
1,22.1,Erythema,17052501,3
2,22.1,Pharyngeal paraesthesia,17052501,3
3,22.1,Paraesthesia oral,17052501,3
0,22.1,Osteonecrosis of jaw,17052512,2
1,22.1,Neutropenia,17052512,1
2,22.1,Cholestasis,17052512,2
3,22.1,Platelet count decreased,17052512,6
4,22.1,Disease progression,17052512,6
5,22.1,Febrile neutropenia,17052512,6
6,22.1,Rash,17052512,1
0,22.1,Product quality issue,17052554,6
1,22.1,Chest discomfort,17052554,6
2,22.1,Erythema,17052554,6
3,22.1,Back pain,17052554,6
0,22.1,Fall,17052555,
0,22.1,Livedo reticularis,17052565,1
1,22.1,Chest discomfort,17052565,1
2,22.1,Oxygen saturation decreased,17052565,1
3,22.1,Erythema,17052565,1
0,22.1,Pneumonitis,17052568,6
1,22.1,Anaemia,17052568,6
2,22.1,Dyspnoea,17052568,6
0,22.1,Dyspnoea,17052570,1
1,22.1,Chest discomfort,17052570,1
2,22.1,Abdominal discomfort,17052570,1
3,22.1,Flushing,17052570,1
0,22.1,Disease progression,17052575,
0,22.1,Splenomegaly,17052626,6
1,22.1,Pneumonitis,17052626,6
2,22.1,Lymphadenopathy mediastinal,17052626,6
0,22.1,Chest discomfort,17052628,1
1,22.1,Dyspnoea,17052628,1
0,22.1,Disorientation,17052632,1
1,22.1,Throat tightness,17052632,1
2,22.1,Hyperhidrosis,17052632,1
3,22.1,Pruritus,17052632,1
4,22.1,Blood pressure decreased,17052632,1
5,22.1,Amnesia,17052632,1
6,22.1,Dyspnoea,17052632,1
7,22.1,Limb discomfort,17052632,1
8,22.1,Presyncope,17052632,1
0,22.1,Hot flush,17052633,1
1,22.1,Off label use,17052633,6
2,22.1,Dizziness,17052633,1
3,22.1,Dyspnoea,17052633,1
4,22.1,Product use in unapproved indication,17052633,6
5,22.1,Palpitations,17052633,1
0,22.1,Chills,17052640,2
1,22.1,Dyspnoea,17052640,2
2,22.1,Heart rate decreased,17052640,2
0,22.1,Flushing,17052664,1
1,22.1,Oxygen saturation decreased,17052664,1
2,22.1,Vomiting,17052664,1
3,22.1,Chest discomfort,17052664,1
0,22.1,Flushing,17052666,1
1,22.1,Vomiting,17052666,1
2,22.1,Immediate post-injection reaction,17052666,1
3,22.1,Oxygen saturation abnormal,17052666,1
4,22.1,Chest discomfort,17052666,1
0,22.1,Nausea,17052669,2
1,22.1,Vomiting,17052669,2
2,22.1,Bone marrow failure,17052669,2
3,22.1,Decreased appetite,17052669,2
4,22.1,Asthenia,17052669,2
0,22.1,Pneumonitis,17052674,1
0,22.1,Mouth ulceration,17052679,3
1,22.1,Oral pain,17052679,6
2,22.1,Diarrhoea,17052679,6
3,22.1,Blood pressure increased,17052679,2
4,22.1,Pain in extremity,17052679,6
5,22.1,Weight decreased,17052679,6
6,22.1,Decreased appetite,17052679,2
7,22.1,Chapped lips,17052679,6
8,22.1,Asthenia,17052679,6
9,22.1,Oedema peripheral,17052679,6
10,22.1,Skin exfoliation,17052679,3
11,22.1,Gingival pain,17052679,6
12,22.1,Fatigue,17052679,6
0,22.1,Peritoneal fibrosis,17052697,6
0,22.1,Arthralgia,17052699,2
1,22.1,Myalgia,17052699,2
2,22.1,Bone pain,17052699,2
0,22.1,Cerebral haemorrhage,17052742,6
1,22.1,Metastases to central nervous system,17052742,2
0,22.1,Underdose,17052788,6
1,22.1,Internal haemorrhage,17052788,6
2,22.1,Full blood count decreased,17052788,6
3,22.1,Liver disorder,17052788,6
0,22.1,Dizziness,17052794,
1,22.1,Flushing,17052794,
2,22.1,Feeling abnormal,17052794,
3,22.1,Infusion related reaction,17052794,
4,22.1,Nausea,17052794,
0,22.1,Bone disorder,17052802,6
1,22.1,Osteonecrosis of jaw,17052802,6
0,22.1,Osteonecrosis of jaw,17052803,2
1,22.1,Bone disorder,17052803,2
0,22.1,Disease progression,17052807,
0,22.1,Osteonecrosis of jaw,17052809,1
1,22.1,Exposed bone in jaw,17052809,1
0,22.1,Death,17052812,
0,22.1,Disease progression,17052827,
0,22.1,Non-small cell lung cancer,17052831,5
0,22.1,Hospitalisation,17052843,
0,22.1,Loose tooth,17052847,3
1,22.1,Hypoaesthesia,17052847,3
2,22.1,Paraesthesia,17052847,6
3,22.1,Disturbance in attention,17052847,6
4,22.1,Memory impairment,17052847,3
5,22.1,Arthralgia,17052847,3
6,22.1,Fatigue,17052847,3
7,22.1,Oral mucosal erythema,17052847,6
8,22.1,Neuropathy peripheral,17052847,3
9,22.1,Myalgia,17052847,3
10,22.1,Oral fungal infection,17052847,6
11,22.1,Oral pain,17052847,6
0,22.1,Altered state of consciousness,17052890,6
0,22.1,Neoplasm progression,17052926,
1,22.1,Head injury,17052926,
2,22.1,Rib fracture,17052926,
0,22.1,Asthenia,17053023,1
1,22.1,Neutropenia,17053023,1
2,22.1,Mood altered,17053023,1
0,22.1,Diarrhoea,17053087,1
1,22.1,Staphylococcal infection,17053087,3
2,22.1,White blood cell count decreased,17053087,6
3,22.1,Asthenia,17053087,3
4,22.1,Skin ulcer,17053087,3
5,22.1,Vomiting,17053087,1
6,22.1,Fatigue,17053087,3
7,22.1,Incorrect dosage administered,17053087,6
0,22.1,Hypercholesterolaemia,17053110,6
0,22.1,Product use issue,17053111,6
1,22.1,Neoplasm progression,17053111,6
2,22.1,Product prescribing error,17053111,6
3,22.1,Off label use,17053111,6
4,22.1,Neutropenia,17053111,3
0,22.1,Hair texture abnormal,17053114,3
1,22.1,Hair disorder,17053114,3
2,22.1,Madarosis,17053114,3
3,22.1,Hair colour changes,17053114,3
4,22.1,Alopecia,17053114,3
0,22.1,Laryngitis,17053120,1
1,22.1,Speech disorder,17053120,3
0,22.1,Liver disorder,17053170,6
1,22.1,Rash,17053170,1
2,22.1,Breast cancer,17053170,6
3,22.1,Rash erythematous,17053170,1
4,22.1,Skin toxicity,17053170,6
5,22.1,Malignant neoplasm progression,17053170,6
6,22.1,Drug ineffective,17053170,6
0,22.1,Stomatitis,17053183,2
1,22.1,Weight increased,17053183,3
2,22.1,Tongue movement disturbance,17053183,3
3,22.1,Aphthous ulcer,17053183,2
4,22.1,Glossodynia,17053183,3
5,22.1,Eye irritation,17053183,3
6,22.1,Blood sodium decreased,17053183,6
0,22.1,Fatigue,17053184,6
1,22.1,Loss of personal independence in daily activities,17053184,6
2,22.1,Asthenia,17053184,6
3,22.1,Hypersomnia,17053184,6
4,22.1,Dyspnoea,17053184,6
0,22.1,Neoplasm progression,17053187,6
0,22.1,Nausea,17053189,1
0,22.1,Neoplasm progression,17053201,6
0,22.1,White blood cell count decreased,17053204,6
0,22.1,Vomiting,17053208,3
0,22.1,Neoplasm progression,17053209,6
0,22.1,Neoplasm progression,17053210,6
1,22.1,Anaemia,17053210,6
0,22.1,Musculoskeletal pain,17053212,6
1,22.1,Neoplasm progression,17053212,6
0,22.1,Platelet count decreased,17053214,6
0,22.1,Hypovolaemic shock,17053383,1
1,22.1,Diarrhoea,17053383,1
2,22.1,Renal failure,17053383,1
0,22.1,Constipation,17053423,
1,22.1,Fatigue,17053423,
2,22.1,Pain in extremity,17053423,
3,22.1,Haemorrhage,17053423,
0,22.1,Pneumonia,17053437,6
1,22.1,Pleural effusion,17053437,6
0,22.1,Hypoxia,17053452,5
1,22.1,Pleural effusion,17053452,6
2,22.1,Dyspnoea,17053452,5
0,22.1,Alopecia,17053464,6
0,22.1,Abdominal pain,17053466,
1,22.1,Diarrhoea,17053466,
2,22.1,Vomiting,17053466,
3,22.1,Nausea,17053466,
4,22.1,Fatigue,17053466,
0,22.1,Arthralgia,17053491,6
1,22.1,Alopecia,17053491,6
2,22.1,Anaemia,17053491,6
0,22.1,Fatigue,17053495,6
0,22.1,Oral herpes,17053521,6
1,22.1,Genital herpes,17053521,6
0,22.1,Altered state of consciousness,17053523,5
1,22.1,Anaphylactic reaction,17053523,5
2,22.1,Coronary artery occlusion,17053523,5
3,22.1,Seizure,17053523,5
4,22.1,Cardiac arrest,17053523,5
0,22.1,Recall phenomenon,17053524,2
1,22.1,Traumatic lung injury,17053524,2
2,22.1,Bilevel positive airway pressure,17053524,2
3,22.1,Pulmonary oedema,17053524,2
4,22.1,Walking disability,17053524,2
5,22.1,Hypoxia,17053524,2
6,22.1,Physical deconditioning,17053524,2
7,22.1,Pyrexia,17053524,2
8,22.1,Radiation pneumonitis,17053524,2
9,22.1,Dyspnoea,17053524,2
10,22.1,Non-cardiogenic pulmonary oedema,17053524,2
11,22.1,Pneumonia,17053524,2
0,22.1,Heart rate increased,17053527,1
1,22.1,Chest discomfort,17053527,1
2,22.1,Flushing,17053527,1
3,22.1,Erythema,17053527,1
4,22.1,Blood pressure increased,17053527,1
0,22.1,Death,17053529,5
0,22.1,Flushing,17053536,1
1,22.1,Chest discomfort,17053536,1
2,22.1,Palpitations,17053536,1
3,22.1,Off label use,17053536,1
4,22.1,Dizziness,17053536,1
0,22.1,Chest discomfort,17053541,1
0,22.1,Malaise,17053547,2
1,22.1,Pulse abnormal,17053547,2
2,22.1,Dyspnoea,17053547,2
3,22.1,Cold sweat,17053547,2
4,22.1,Heart rate increased,17053547,2
5,22.1,Hypopnoea,17053547,2
6,22.1,Blood pressure decreased,17053547,2
0,22.1,Hot flush,17053552,1
1,22.1,Palpitations,17053552,1
2,22.1,Chest discomfort,17053552,1
3,22.1,Flushing,17053552,1
0,22.1,Throat tightness,17053555,1
1,22.1,Chest discomfort,17053555,1
2,22.1,Feeling hot,17053555,1
0,22.1,Bone marrow failure,17053559,6
1,22.1,Rib deformity,17053559,6
2,22.1,Myalgia,17053559,6
3,22.1,Arthralgia,17053559,6
4,22.1,White blood cell count decreased,17053559,6
5,22.1,Musculoskeletal chest pain,17053559,6
0,22.1,Sciatica,17053564,2
0,22.1,Diabetes mellitus,17053570,6
0,22.1,Death,17053571,5
0,22.1,Neuropathy peripheral,17053581,1
0,22.1,Hospitalisation,17053594,
1,22.1,Therapy cessation,17053594,
0,22.1,Ophthalmoplegia,17053596,3
0,22.1,Constipation,17053597,1
1,22.1,Nausea,17053597,1
2,22.1,Reflux gastritis,17053597,1
0,22.1,Prostate cancer,17053620,5
0,22.1,Death,17053629,5
0,22.1,Death,17053667,5
0,22.1,Death,17053669,5
0,22.1,Malignant neoplasm progression,17053689,6
1,22.1,Prostatic specific antigen increased,17053689,6
2,22.1,Mouth injury,17053689,6
3,22.1,Metastases to bone,17053689,6
4,22.1,Pneumonia fungal,17053689,6
5,22.1,Decreased appetite,17053689,6
6,22.1,Bone pain,17053689,6
7,22.1,Fungal infection,17053689,6
8,22.1,Gait disturbance,17053689,6
9,22.1,Swelling face,17053689,6
10,22.1,Neuropathy peripheral,17053689,3
11,22.1,Hypoaesthesia,17053689,6
12,22.1,Jaw disorder,17053689,6
13,22.1,Back pain,17053689,6
14,22.1,Muscular weakness,17053689,6
15,22.1,Metastasis,17053689,6
16,22.1,Pain in jaw,17053689,6
17,22.1,Fatigue,17053689,6
0,22.1,Infection,17053691,
1,22.1,Sepsis,17053691,
0,22.1,Death,17053699,5
0,22.1,Blood testosterone,17053708,6
1,22.1,Drug ineffective,17053708,6
0,22.1,Disease progression,17053785,6
0,22.1,Hypoglycaemia,17053847,6
1,22.1,Product use in unapproved indication,17053847,6
0,22.1,Haemoptysis,17053858,5
0,22.1,Neutropenia,17053877,1
0,22.1,Fall,17053888,2
1,22.1,Pain,17053888,2
2,22.1,Rash macular,17053888,6
3,22.1,Poor venous access,17053888,6
4,22.1,Malaise,17053888,6
5,22.1,Vaginal infection,17053888,6
6,22.1,Injection site rash,17053888,6
7,22.1,Cerebrovascular accident,17053888,6
8,22.1,Rash,17053888,6
0,22.1,Altered state of consciousness,17054007,2
1,22.1,Subdural haematoma,17054007,2
2,22.1,Haemoglobin decreased,17054007,2
3,22.1,Asthenia,17054007,2
4,22.1,Thrombocytopenia,17054007,2
5,22.1,Somnolence,17054007,2
0,22.1,Asthenia,17054012,
1,22.1,Fatigue,17054012,
2,22.1,Nausea,17054012,
3,22.1,Hypophagia,17054012,
0,22.1,Blood count abnormal,17054013,
0,22.1,Death,17054017,
0,22.1,Acute hepatic failure,17054024,6
1,22.1,Hepatitis B reactivation,17054024,6
0,22.1,Disease progression,17054027,
0,22.1,Cholelithiasis,17054050,6
1,22.1,Diabetes mellitus,17054050,6
2,22.1,Lipids abnormal,17054050,6
3,22.1,Hepatic steatosis,17054050,6
0,22.1,Product prescribing error,17054111,6
0,22.1,Radiation pneumonitis,17054112,3
0,22.1,Malignant neoplasm progression,17054115,6
0,22.1,Osteonecrosis,17054154,3
1,22.1,Swelling,17054154,6
2,22.1,Pain in jaw,17054154,6
0,22.1,Nausea,17054182,1
1,22.1,Back pain,17054182,1
2,22.1,Malaise,17054182,1
3,22.1,Dyspnoea,17054182,1
4,22.1,Flushing,17054182,1
5,22.1,Eye movement disorder,17054182,1
6,22.1,Chest discomfort,17054182,1
7,22.1,Depressed level of consciousness,17054182,1
8,22.1,Headache,17054182,1
9,22.1,Vomiting,17054182,1
0,22.1,Pericardial effusion,17054201,1
0,22.1,Neuromyopathy,17054226,3
1,22.1,Posture abnormal,17054226,3
2,22.1,Dyspnoea,17054226,3
0,22.1,Diarrhoea,17054260,6
1,22.1,Eye swelling,17054260,6
2,22.1,Abdominal pain,17054260,6
3,22.1,Back pain,17054260,6
0,22.1,Cardiomegaly,17054298,6
1,22.1,Malignant neoplasm progression,17054298,6
